FDA Clears 1st Spinopelvic Fixation System with Nanotechnology Designation .

A new approach to sacroiliac joint fixation has received regulatory clearance. Xenix Medical's Riva Anchor system is designed for use at the base of posterior lumbar or thoracolumbar fusion constructs, incorporating a proprietary micro- and nanoscale surface intended to support bone growth. The company is preparing for a limited commercial launch. While the technology introduces another fixation option for complex spine surgery, its comparative fusion rates, implant longevity and clinical outcomes require further evaluation.